Rodríguez-Calvo T - Search Results

1

Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population.

Sanz-Ramos M, Rodríguez-Calvo T, Sevilla N. Sanz-Ramos M, et al. PLoS One. 2012;7(6):e39941. doi: 10.1371/journal.pone.0039941. Epub 2012 Jun 28. PLoS One. 2012. PMID: 22761933 Free PMC article.

2

Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10.

Díaz-San Segundo F, Rodríguez-Calvo T, de Avila A, Sevilla N. Díaz-San Segundo F, et al. PLoS One. 2009 May 21;4(5):e5659. doi: 10.1371/journal.pone.0005659. PLoS One. 2009. PMID: 19478852 Free PMC article.

3

New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.

Rodríguez-Calvo T, Ojosnegros S, Sanz-Ramos M, García-Arriaza J, Escarmís C, Domingo E, Sevilla N. Rodríguez-Calvo T, et al. PLoS One. 2010 Apr 29;5(4):e10414. doi: 10.1371/journal.pone.0010414. PLoS One. 2010. PMID: 20454676 Free PMC article.

4

A replication analysis of foot-and-mouth disease virus in swine lymphoid tissue might indicate a putative carrier stage in pigs.

Rodríguez-Calvo T, Díaz-San Segundo F, Sanz-Ramos M, Sevilla N. Rodríguez-Calvo T, et al. Vet Res. 2011 Feb 7;42(1):22. doi: 10.1186/1297-9716-42-22. Vet Res. 2011. PMID: 21314905 Free PMC article.

5

Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor.

Calvo-Pinilla E, Rodríguez-Calvo T, Anguita J, Sevilla N, Ortego J. Calvo-Pinilla E, et al. PLoS One. 2009;4(4):e5171. doi: 10.1371/journal.pone.0005171. Epub 2009 Apr 9. PLoS One. 2009. PMID: 19357779 Free PMC article.

6

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection.

Calvo-Pinilla E, Rodríguez-Calvo T, Sevilla N, Ortego J. Calvo-Pinilla E, et al. Vaccine. 2009 Dec 11;28(2):437-45. doi: 10.1016/j.vaccine.2009.10.027. Epub 2009 Oct 24. Vaccine. 2009. PMID: 19857449

7

Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo.

Rodríguez-Calvo T, Rojas JM, Martín V, Sevilla N. Rodríguez-Calvo T, et al. J Virol. 2014 Jan;88(2):859-67. doi: 10.1128/JVI.02697-13. Epub 2013 Oct 30. J Virol. 2014. PMID: 24173228 Free PMC article.

8

T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.

Rojas JM, Rodríguez-Calvo T, Peña L, Sevilla N. Rojas JM, et al. Vaccine. 2011 Sep 16;29(40):6848-57. doi: 10.1016/j.vaccine.2011.07.061. Epub 2011 Jul 30. Vaccine. 2011. PMID: 21807057

9

Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoire.

Rojas JM, Rodríguez-Calvo T, Sevilla N. Rojas JM, et al. Vet Res. 2017 Jun 29;48(1):38. doi: 10.1186/s13567-017-0444-3. Vet Res. 2017. PMID: 28662714 Free PMC article.

10

Direct infection of dendritic cells during chronic viral infection suppresses antiviral T cell proliferation and induces IL-10 expression in CD4 T cells.

Baca Jones C, Filippi C, Sachithanantham S, Rodriguez-Calvo T, Ehrhardt K, von Herrath M. Baca Jones C, et al. PLoS One. 2014 Mar 10;9(3):e90855. doi: 10.1371/journal.pone.0090855. eCollection 2014. PLoS One. 2014. PMID: 24613988 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters